Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial

Journal of the American College of Cardiology

Volumn 67, Issue 3, 2016, Pages 344-346

  Stähli, Barbara E ^a   Tardif, Jean Claude ^a   Carrier, Michel ^a   Gallo, Richard ^a   Emery, Robert W ^a   Robb, Stephen ^a   Cournoyer, Daniel ^a   Blondeau, Lucie ^a   Johnson, Dominique ^a   Mann, Jessica ^a   Lespérance, Jacques ^a   Guertin, Marie Claude ^a   L'Allier, Philippe L ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INCLACUMAB; PADGEM PROTEIN; PLACEBO; CARDIOVASCULAR AGENT; MONOCLONAL ANTIBODY;

ANGIOCARDIOGRAPHY; ARTERY DIAMETER; BLOOD ANALYSIS; CANADA; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; LETTER; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; OFF PUMP CORONARY SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PHASE 1 CLINICAL TRIAL (TOPIC); POST HOC ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAPHENOUS VEIN GRAFT; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES; ACUTE CORONARY SYNDROME; ADVERSE EFFECTS; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; ANTIBODIES, MONOCLONAL; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84957824881     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.071     Document Type: Letter

References (5)

1. C.N. Hess, R.D. Lopes, C.M. Gibson, and et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV Circulation 130 2014 1445 1451
2. J.F. Tanguay, P. Geoffroy, M.G. Sirois, and et al. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1 Thromb Haemost 91 2004 1186 1193
3. P.C. Burger, and D.D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2003 2661 2666
4. D. Kling, C. Stucki, S. Kronenberg, and et al. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies Thromb Res 131 2013 401 410
5. J.C. Tardif, J.F. Tanguay, S.S. Wright, and et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial J Am Coll Cardiol 61 2013 2048 2055